In a 49-year-old female patient taking lisinopril 20 mg twice daily with uncontrolled hypertension, is adding amlodipine appropriate and what starting dose should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Adding Amlodipine to Lisinopril for Uncontrolled Hypertension

Yes, adding amlodipine is an excellent choice for this patient, and you should start with amlodipine 5 mg once daily. This combination of an ACE inhibitor with a calcium channel blocker (CCB) is specifically recommended as first-line dual therapy by multiple international guidelines and has superior cardiovascular outcomes compared to other combinations 1.

Why This Combination is Optimal

The ACE inhibitor/CCB combination is strongly supported by high-quality evidence:

  • The ACCOMPLISH trial demonstrated that benazepril plus amlodipine was superior to benazepril plus hydrochlorothiazide in reducing cardiovascular death and major adverse cardiovascular events (HR 0.80; 95% CI 0.72-0.90) 2
  • Multiple international guidelines (ISH 2020, Hypertension Canada 2016-2020, ACC/AHA 2017) explicitly recommend this combination as preferred dual therapy 3, 1, 4
  • This combination provides complementary mechanisms: the ACE inhibitor blocks the renin-angiotensin system while the CCB provides vasodilation, resulting in approximately 5-fold greater BP reduction than simply doubling a single agent 2

Starting Dose and Titration

Start with amlodipine 5 mg once daily 5. This is the FDA-approved initial dose for hypertension and is appropriate when adding to existing therapy.

Dosing Algorithm:

  1. Initial: Add amlodipine 5 mg once daily to current lisinopril 20 mg BID
  2. Reassess in 7-14 days: Check BP response 5
  3. If BP not at goal: Increase amlodipine to 10 mg once daily (maximum dose) 5
  4. If still uncontrolled: Consider adding a thiazide-like diuretic (chlorthalidone or indapamide preferred over hydrochlorothiazide) as third agent 3, 2, 1

Important Consideration About Current Lisinopril Dosing

Critical caveat: Your patient is taking lisinopril 20 mg twice daily (BID), which totals 40 mg/day. However, lisinopril is designed for once-daily dosing 6. The FDA label clearly states "administered in a single daily dose" with a usual range of 20-40 mg once daily 6.

Recent real-world evidence shows no benefit of BID versus once-daily dosing for lisinopril—there were no differences in systolic or diastolic BP control between BID and once-daily regimens 7. In fact, BID dosing may increase adverse events (increased angioedema risk with lisinopril 10 mg BID vs 20 mg once daily, OR 2.27) 7.

Recommended Adjustment:

Consider consolidating to lisinopril 40 mg once daily (or 20 mg once daily if tolerating lower total dose) before or concurrent with adding amlodipine. This simplifies the regimen, improves adherence, and maintains the same total daily dose with equivalent efficacy 7.

Expected Outcomes

With the lisinopril/amlodipine combination, you should expect:

  • BP reduction: Mean decreases of 10-15 mmHg systolic and 5-10 mmHg diastolic 8, 9
  • Target achievement: 64-83% of patients reach target BP within 6 months 2, 8, 9
  • Cardiovascular protection: Reduced left ventricular mass and improved diastolic function 9, 10
  • Good tolerability: Well-tolerated with minimal serious adverse effects 9, 11

Monitoring and Follow-up

  • Reassess BP in 2 weeks to evaluate response and check for adverse effects (peripheral edema from amlodipine, cough from lisinopril)
  • Target BP should be achieved within 3 months 1
  • Monitor for hyperkalemia and renal function given ACE inhibitor use
  • Encourage home BP monitoring for better assessment of control 3

Common Pitfalls to Avoid

  1. Don't use BID dosing for lisinopril when once-daily is equally effective and safer 7
  2. Don't start with amlodipine 2.5 mg unless the patient is elderly, frail, or has hepatic insufficiency—5 mg is the appropriate starting dose for most adults 5
  3. Don't add a thiazide diuretic as the second agent when a CCB is available—the ACE inhibitor/CCB combination has superior outcomes 2, 12
  4. Don't wait too long to uptitrate—if BP remains uncontrolled after 2 weeks, increase amlodipine to 10 mg rather than accepting suboptimal control

References

Related Questions

How should I manage a hypertensive patient currently taking lisinopril 10 mg daily and amlodipine 5 mg daily?
What is the appropriate blood pressure control strategy for a 37-year-old African American male currently taking lisinopril 10 mg daily and amlodipine 10 mg daily?
In a patient allergic to lisinopril and unable to tolerate beta‑blockers, amlodipine, or losartan, what is the appropriate next antihypertensive treatment?
What antihypertensive regimen can be used for a patient who is allergic to lisinopril, cannot tolerate losartan, and is already on amlodipine?
In a patient with systolic blood pressure in the 160 mm Hg range while taking amlodipine (Norvasc) 5 mg and lisinopril 40 mg daily, does research recommend increasing the amlodipine dose or adding a new antihypertensive medication to achieve control?
In a 44-year-old woman presenting to the emergency department with abnormal uterine bleeding, what laboratory and diagnostic workup is indicated?
What are the indications for a biventricular implantable cardioverter‑defibrillator (Bi‑V AICD)?
What are the causes and treatment options for increased oral secretion (drooling) while sleeping?
What does biapical consolidation on a chest X‑ray indicate and what are the next steps?
What is the appropriate evaluation and management of sore throat (pharyngitis) in a patient taking amantadine?
Can the inactivated influenza vaccine, RSV vaccine, and Tdap (tetanus‑diphtheria‑pertussis) vaccine be administered together during pregnancy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.